Arjun Law/LinkedIn
May 15, 2026, 10:28
Arjun Law: Transplant Should Always Be a Consideration for Severe AA Irrespective of Donor
Arjun Law, Associate Professor at University of Washington and Fred Hutch, shared a post on LinkedIn about a recent article he and Jeffrey H. Lipton co-authored, published in Ammerican Journal of Hematology, adding:
“Plugging our latest review article on AA management from a very practical, clinic-focused perspective.
Bottom line, transplant should always be a consideration for severe AA irrespective of donor.”
Title: Allogeneic HSCT in Aplastic Anemia: Current Evidence, Controversies, and Practical Decision-Making
Authors: Arjun Datt Law, Jeffrey H. Lipton
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
-
Aug 23, 2026, 16:03Balaji Balagani: Major Causes of Sudden Cardiac Death in Children
-
Aug 23, 2026, 16:02Bartosz Hudzik: What’s Hot at ESC Congress 2026